(Total Views: 340)
Posted On: 05/07/2019 8:40:34 AM
Post# of 107225
$CYDY: FDA Grants CytoDyn Fast Track Designation for Leronlimab (PRO 140) in metastatic Triple-Negative Breast Cancer, an Unmet Medical Need
https://www.otcmarkets.com/stock/CYDY/news/FD...?id=227234
I've said in the past "accumulate" this ticker, it has huge upside for those with patience. I expect CYDY will get to .55 area and struggle with convertibles at that level if the volume is not there to crush it. Additionally, the big booster could happen at any time----big pharma partnership or licensing deal, keep on radar.
https://www.otcmarkets.com/stock/CYDY/news/FD...?id=227234
I've said in the past "accumulate" this ticker, it has huge upside for those with patience. I expect CYDY will get to .55 area and struggle with convertibles at that level if the volume is not there to crush it. Additionally, the big booster could happen at any time----big pharma partnership or licensing deal, keep on radar.
(0)
(0)
Sojourner here following God, obeying God, and cleaving to Him. The journey is onward.
